Skip to content

enVista® Toric IOL MX60ET (REF MXUET200+180)Recalls & reported problems

Bausch & Lomb Incorporated · enVista one-piece hydrophobic acrylic toric intraocular lens +18.00D SE / +2.00D CYL · Class 3 · Implant

All models of enVista Toric IOL (450)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770555649), received between May 31, 2023 and May 31, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Unintended Movement” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unintended Movement1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 31, 2023Unintended Movement; Unintended Movement

    IT WAS REPORTED ONE DAY AFTER IMPLANTATION OF AN INTRAOCULAR LENS INTO THE LEFT EYE (OS) THE LENS ROTATED OUT OF POSITION. APPROXIMATELY ONE-MONTH POST-OP, THE IOL WAS REPOSITIONED TO ITS INTENDED POSITION. IN THE SURGEON''S OPINION, THE CAUSE OF THE IOL ROTATION IS UNKNOWN. PATIENT OUTCOME IS GOOD.

    Patient problems: Blurred Vision

    MAUDE report 17032574 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page